{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:04:03Z","timestamp":1789095843484,"version":"build-2803163510"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171786"],"award-info":[{"award-number":["82171786"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.clim.2024.110231","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T15:49:39Z","timestamp":1714405779000},"page":"110231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Animal models of studying the pathogenesis of multi-organ tissue damage in lupus"],"prefix":"10.1016","volume":"263","author":[{"given":"Xuefei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Min","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2024.110231_bb0005","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2024.110231_bb0010","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.clim.2024.110231_bb0015","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2024.110231_bb0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","article-title":"Autoimmunity and organ damage in systemic lupus erythematosus","volume":"21","author":"Tsokos","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2024.110231_bb0025","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","article-title":"Management strategies and future directions for systemic lupus erythematosus in adults","volume":"393","author":"Durcan","year":"2019","journal-title":"Lancet (Lond. Engl.)"},{"key":"10.1016\/j.clim.2024.110231_bb0030","first-page":"663","article-title":"Pathogenesis and targeted treatment of skin injury in SLE, nature reviews","volume":"11","author":"Deng","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2024.110231_bb0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","article-title":"Global epidemiology of systemic lupus erythematosus","volume":"17","author":"Barber","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2024.110231_bb0040","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.molmed.2017.05.006","article-title":"Pathogenesis of human systemic lupus erythematosus: a cellular perspective","volume":"23","author":"Moulton","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.clim.2024.110231_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: new mechanistic insights and future treatment directions","volume":"15","author":"Schwartz","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2024.110231_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.924766","article-title":"The role of organ-deposited IgG in the pathogenesis of multi-organ and tissue damage in systemic lupus erythematosus","volume":"13","author":"Qiu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110231_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102870","article-title":"Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies","volume":"132","author":"Li","year":"2022","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2024.110231_bb0060","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nrrheum.2013.78","article-title":"Gene-function studies in systemic lupus erythematosus","volume":"9","author":"Crisp\u00edn","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2024.110231_bb0065","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cmet.2023.04.004","article-title":"Neurotransmitters arrive to control systemic autoimmunity","volume":"35","author":"Scherlinger","year":"2023","journal-title":"Cell Metab."},{"issue":"Suppl","key":"10.1016\/j.clim.2024.110231_bb0070","article-title":"Systemic lupus erythematosus. A disease with a complex pathogenesis","volume":"vol. 358","author":"Tsokos","year":"2001","journal-title":"Lancet (Lond. Engl.)"},{"key":"10.1016\/j.clim.2024.110231_bb0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/08830185.2020.1742712","article-title":"Contribution of mouse models in our understanding of lupus","volume":"39","author":"Halkom","year":"2020","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.clim.2024.110231_bb0080","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(13)61499-3","article-title":"Clinical aspects of autoimmune rheumatic diseases","volume":"382","author":"Goldblatt","year":"2013","journal-title":"Lancet (Lond. Engl.)"},{"key":"10.1016\/j.clim.2024.110231_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102490","article-title":"Are lupus animal models useful for understanding and developing new therapies for human SLE?","volume":"112","author":"Moore","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2024.110231_bb0090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.clim.2013.03.006","article-title":"Bridging the gap between autoinflammation and autoimmunity","volume":"147","author":"Hedrich","year":"2013","journal-title":"Clin. Immunol. (Orlando, Fla.)"},{"key":"10.1016\/j.clim.2024.110231_bb0095","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41584-021-00652-9","article-title":"Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases","volume":"17","author":"Szekanecz","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2024.110231_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109055","article-title":"Melanocyte-secreted fibromodulin constrains skin inflammation in mice injected with lupus serum","volume":"241","author":"Halasi","year":"2022","journal-title":"Clin. Immunol. (Orlando, Fla.)"},{"key":"10.1016\/j.clim.2024.110231_bb0105","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.4049\/jimmunol.0902514","article-title":"Lupus serum IgG induces skin inflammation through the TNFR1 signaling pathway","volume":"184","author":"Deng","year":"2010","journal-title":"J. Immunol. (Baltimore Md.: 1950)"},{"key":"10.1016\/j.clim.2024.110231_bb0110","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.4049\/jimmunol.1201594","article-title":"Human lupus serum induces neutrophil-mediated organ damage in mice that is enabled by Mac-1 deficiency","volume":"189","author":"Rosetti","year":"2012","journal-title":"J. Immunol. (Baltimore Md.: 1950)"},{"key":"10.1016\/j.clim.2024.110231_bb0115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0065-2776(08)60444-7","article-title":"The immunology and pathology of NZB mice","volume":"9","author":"Howie","year":"1968","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.clim.2024.110231_bb0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/249043a0","article-title":"In vitro suppression of cell mediated autoimmunity in NZB mice","volume":"249","author":"Russell","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.clim.2024.110231_bb0125","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1084\/jem.148.5.1198","article-title":"Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains","volume":"148","author":"Andrews","year":"1978","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2024.110231_bb0130","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.4049\/jimmunol.121.6.2213","article-title":"Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease","volume":"121","author":"Izui","year":"1978","journal-title":"J. Immunol. (Baltimore Md.: 1950)"},{"key":"10.1016\/j.clim.2024.110231_bb0135","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/art.1780221105","article-title":"A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation","volume":"22","author":"Murphy","year":"1979","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2024.110231_bb0140","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood.V82.3.837.837","article-title":"Development and characterization of monoclonal antiplatelet autoantibodies from autoimmune thrombocytopenic purpura-prone (NZW x BXSB)F1 mice","volume":"82","author":"Mizutani","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.clim.2024.110231_bb0145","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/BOR.0000000000000412","article-title":"An update on lupus animal models","volume":"29","author":"Li","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.clim.2024.110231_bb0150","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1084\/jem.180.6.2341","article-title":"Induction of lupus-associated autoantibodies in BALB\/c mice by intraperitoneal injection of pristane","volume":"180","author":"Satoh","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2024.110231_bb0155","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.38298","article-title":"Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic Lupus erythematosus","volume":"66","author":"Yokogawa","year":"2014","journal-title":"Arthrit. Rrheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.clim.2024.110231_bb0160","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1073\/pnas.85.7.2260","article-title":"Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype","volume":"85","author":"Mendlovic","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.clim.2024.110231_bb0165","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/intimm\/5.10.1293","article-title":"The role of the 16\/6 idiotype network in the induction and manifestations of systemic lupus erythematosus","volume":"5","author":"Waisman","year":"1993","journal-title":"Int. Immunol."},{"key":"10.1016\/j.clim.2024.110231_bb0170","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.4049\/jimmunol.1401129","article-title":"Selective memory to apoptotic cell-derived self-antigens with implications for systemic lupus erythematosus development","volume":"197","author":"Duhlin","year":"2016","journal-title":"J. Immunol. (Baltimore Md.: 1950)"},{"key":"10.1016\/j.clim.2024.110231_bb0175","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrrheum.2016.157","article-title":"Autoimmunity: apoptotic cells induce immune memory","volume":"12","author":"Onuora","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2024.110231_bb0180","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.4049\/jimmunol.130.6.2693","article-title":"Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA\/2 spleen cells of H-2-different nonirradiated F1 mice","volume":"130","author":"Van Rappard-Van Der","year":"1983","journal-title":"J. Immunol. (Baltimore Md.: 1950)"},{"key":"10.1016\/j.clim.2024.110231_bb0185","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aar7201","article-title":"Translocation of a gut pathobiont drives autoimmunity in mice and humans","volume":"359","author":"Manfredo Vieira","year":"2018","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.clim.2024.110231_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102844","article-title":"Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: an EXPLORER trial","volume":"130","author":"Huang","year":"2022","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2024.110231_bb0195","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/path.1711580410","article-title":"Transfer of anti-glomerular basement membrane antibody-induced glomerulonephritis in inbred rats with isologous antibodies from the urine of nephritic rats","volume":"158","author":"Sado","year":"1989","journal-title":"J. Pathol."},{"key":"10.1016\/j.clim.2024.110231_bb0200","first-page":"181","article-title":"Autoantibodies and SLE: the threshold for disease, nature reviews","volume":"10","author":"Olsen","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2024.110231_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1174","article-title":"Lupus IgG deposition causes arthritis but inhibits bone destruction through competitive occupation of Fc\u03b3RI and reduced RANKL signalling","volume":"9","author":"Qiao","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.clim.2024.110231_bb0210","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.3389\/fimmu.2019.03020","article-title":"Predominant role of immunoglobulin G in the pathogenesis of splenomegaly in murine lupus","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110231_bb0215","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3389\/fimmu.2018.01457","article-title":"Role of hepatic deposited immunoglobulin G in the pathogenesis of liver damage in systemic lupus erythematosus","volume":"9","author":"Fang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110231_bb0220","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41584-020-0480-7","article-title":"New insights into the role of antinuclear antibodies in systemic lupus erythematosus","volume":"16","author":"Pisetsky","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.clim.2024.110231_bb0225","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41581-023-00786-x","article-title":"The immunoregulatory roles of non-haematopoietic cells in the kidney","volume":"20","author":"Tsokos","year":"2024","journal-title":"Nat. Rev. Nephrol"},{"key":"10.1016\/j.clim.2024.110231_bb0230","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.108.771170","article-title":"Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury","volume":"120","author":"Mayadas","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.clim.2024.110231_bb0235","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2024.110231_bb0240","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrrheum.2015.151","article-title":"Anti-DNA antibodies--quintessential biomarkers of SLE","volume":"12","author":"Pisetsky","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2024.110231_bb0245","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archderm.1983.01650360056014","article-title":"Usefulness of direct immunofluorescence in patients with lupus erythematosus","volume":"119","author":"Dahl","year":"1983","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clim.2024.110231_bb0250","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jaut.2014.01.021","article-title":"The classification and diagnosis of cutaneous lupus erythematosus","volume":"48-49","author":"Kuhn","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2024.110231_bb0255","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clim.2016.02.007","article-title":"The features of skin inflammation induced by lupus serum","volume":"165","author":"Liu","year":"2016","journal-title":"Clin. Immunol. (Orlando, Fla.)"},{"key":"10.1016\/j.clim.2024.110231_bb0260","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3389\/fimmu.2017.01723","article-title":"The role of estrogen membrane receptor (G protein-coupled estrogen receptor 1) in skin inflammation induced by systemic lupus erythematosus serum IgG","volume":"8","author":"Cai","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110231_bb0265","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41584-019-0211-0","article-title":"B cell checkpoints in autoimmune rheumatic diseases","volume":"15","author":"Rubin","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2024.110231_bb0270","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/ard-2022-222839","article-title":"Clinical trials in systemic lupus erythematosus: the dilemma-why have phase III trials failed to confirm the promising results of phase II trials?","volume":"82","author":"Lorenzo-Vizcaya","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2024.110231_bb0275","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1126\/science.1230720","article-title":"Anti-inflammatory therapy in chronic disease: challenges and opportunities","volume":"339","author":"Tabas","year":"2013","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.clim.2024.110231_bb0280","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/nm1304","article-title":"Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors","volume":"11","author":"Deng","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2024.110231_bb0285","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/9554","article-title":"Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis","volume":"5","author":"Deng","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2024.110231_bb0290","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.4049\/jimmunol.167.8.4616","article-title":"Intracisternally localized bacterial DNA containing CpG motifs induces meningitis","volume":"167","author":"Deng","year":"2001","journal-title":"J. Immunol. (Baltimore Md.: 1950)"},{"key":"10.1016\/j.clim.2024.110231_bb0295","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/1529-0131(200010)43:10<2283::AID-ANR16>3.0.CO;2-9","article-title":"The major role of macrophages and their product tumor necrosis factor alpha in the induction of arthritis triggered by bacterial DNA containing CpG motifs","volume":"43","author":"Deng","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2024.110231_bb0300","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1002\/art.24686","article-title":"Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells","volume":"60","author":"Eloranta","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2024.110231_bb0305","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI23025","article-title":"Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9","volume":"115","author":"Means","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2024.110231_bb0310","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1084\/jem.20132522","article-title":"Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"211","author":"Sisirak","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2024.110231_bb0315","first-page":"509","article-title":"FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus","volume":"10","author":"Batteux","year":"1999","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.clim.2024.110231_bb0320","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nri2358","article-title":"Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases","volume":"8","author":"Gilliet","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2024.110231_bb0325","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.immuni.2023.08.009","article-title":"Tertiary lymphoid structures and B cells: an intratumoral immunity cycle","volume":"56","author":"Fridman","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2024.110231_bb0330","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/imm.12908","article-title":"The role of neutrophils in skin damage induced by tissue-deposited lupus IgG","volume":"154","author":"Guo","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2024.110231_bb0335","doi-asserted-by":"crossref","first-page":"73ra20","DOI":"10.1126\/scitranslmed.3001201","article-title":"Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus","volume":"3","author":"Garcia-Romo","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.clim.2024.110231_bb0340","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s41590-021-00993-3","article-title":"Glutathione peroxidase 4-regulated neutrophil ferroptosis induces systemic autoimmunity","volume":"22","author":"Li","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2024.110231_bb0345","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1002\/art.11237","article-title":"Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus","volume":"48","author":"Ren","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2024.110231_bb0350","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.4049\/jimmunol.1300634","article-title":"T cell CD3\u03b6 deficiency enables multiorgan tissue inflammation","volume":"191","author":"Deng","year":"2013","journal-title":"J. Immunol. (Baltimore Md.: 1950)"},{"key":"10.1016\/j.clim.2024.110231_bb0355","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.4049\/jimmunol.178.3.1938","article-title":"Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus","volume":"178","author":"Li","year":"2007","journal-title":"J. Immunol. (Baltimore Md.: 1950)"},{"key":"10.1016\/j.clim.2024.110231_bb0360","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1172\/JCI1457","article-title":"Altered pattern of TCR\/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain","volume":"101","author":"Liossis","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2024.110231_bb0365","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1182\/blood.V97.12.3851","article-title":"Generation and biochemical analysis of human effector CD4 T cells: alterations in tyrosine phosphorylation and loss of CD3zeta expression","volume":"97","author":"Krishnan","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.clim.2024.110231_bb0370","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1073\/pnas.2000943117","article-title":"Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis","volume":"117","author":"Jing","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.clim.2024.110231_bb0375","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/ard.2003.007336","article-title":"Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States","volume":"63","author":"Parks","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2024.110231_bb0380","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.autrev.2015.08.006","article-title":"Insights into IL-37, the role in autoimmune diseases","volume":"14","author":"Xu","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2024.110231_bb0385","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/art.39328","article-title":"Brief Report: interleukin-38 exerts antiinflammatory functions and is associated with disease activity in systemic lupus erythematosus","volume":"vol. 67","author":"Rudloff","year":"2015","journal-title":"Arthrit. Rrheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.clim.2024.110231_bb0390","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clim.2017.03.015","article-title":"Skin inflammation induced by lupus serum was inhibited in IL-1R deficient mice","volume":"180","author":"Li","year":"2017","journal-title":"Clin. Immunol. (Orlando, Fla.)"},{"key":"10.1016\/j.clim.2024.110231_bb0395","first-page":"749","article-title":"Interleukin-2 and regulatory T cells in rheumatic diseases, nature reviews","volume":"17","author":"Kolios","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2024.110231_bb0400","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.clim.2012.02.005","article-title":"Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury","volume":"143","author":"Hofmann","year":"2012","journal-title":"Clin. Immunol. (Orlando, Fla.)"},{"key":"10.1016\/j.clim.2024.110231_bb0405","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clim.2016.04.010","article-title":"T cells and IL-17 in lupus nephritis","volume":"185","author":"Koga","year":"2017","journal-title":"Clin. Immunol. (Orlando, Fla.)"},{"key":"10.1016\/j.clim.2024.110231_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.103016","article-title":"Fc receptors gone wrong: a comprehensive review of their roles in autoimmune and inflammatory diseases","volume":"21","author":"Chalayer","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2024.110231_bb0415","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00919382","article-title":"The biology and pathology of fc receptors","volume":"13","author":"Sandor","year":"1993","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110231_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.688201","article-title":"Fc gamma receptors as regulators of bone destruction in inflammatory arthritis","volume":"12","author":"Zuo","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110231_bb0425","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s13238-018-0509-8","article-title":"Transmembrane domain dependent inhibitory function of Fc\u03b3RIIB","volume":"9","author":"Wang","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.clim.2024.110231_bb0430","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/0961203315579093","article-title":"Monocyte CD64 expression as a novel biomarker for the disease activity of systemic lupus erythematosus","volume":"24","author":"Kikuchi-Taura","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2024.110231_bb0435","article-title":"Amelioration of lupus serum-induced skin inflammation in CD64-deficient mice","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110231_bb0440","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jphs.2018.05.012","article-title":"Lentivirus-mediated knockdown of Fc\u03b3RI (CD64) attenuated lupus nephritis via inhibition of NF-\u03baB regulating NLRP3 inflammasome activation in MRL\/lpr mice","volume":"137","author":"Zhang","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.clim.2024.110231_bb0445","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.4049\/jimmunol.171.6.3296","article-title":"Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG","volume":"171","author":"B\u00e5ve","year":"2003","journal-title":"J. Immunol. (Baltimore Md.: 1950)"},{"key":"10.1016\/j.clim.2024.110231_bb0450","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1084\/jem.20072413","article-title":"Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake","volume":"205","author":"Willcocks","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2024.110231_bb0455","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1182\/blood.2020004974","article-title":"Fc\u03b3RIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus","volume":"136","author":"Melki","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.clim.2024.110231_bb0460","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nm1288","article-title":"Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts","volume":"11","author":"Floto","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2024.110231_bb0465","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157250","article-title":"Fc\u03b3RIIB regulates autoantibody responses by limiting marginal zone B cell activation","volume":"132","author":"Barlev","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2024.110231_bb0470","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1172\/JCI94039","article-title":"Neutrophil Fc\u03b3RIIA promotes IgG-mediated glomerular neutrophil capture via Abl\/Src kinases","volume":"127","author":"Nishi","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2024.110231_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107749","article-title":"Immunoglobulin G inhibits glucocorticoid-induced osteoporosis through occupation of Fc\u03b3RI","volume":"26","author":"Jiang","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.clim.2024.110231_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102804","article-title":"Antibody glycosylation in autoimmune diseases","volume":"20","author":"Zhou","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2024.110231_bb0485","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nri2765","article-title":"The SYK tyrosine kinase: a crucial player in diverse biological functions","volume":"10","author":"M\u00f3csai","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2024.110231_bb0490","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41588-021-00803-4","article-title":"Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice","volume":"53","author":"Wang","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2024.110231_bb0495","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/art.27452","article-title":"Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone mice","volume":"62","author":"Deng","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2024.110231_bb0500","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/exd.12986","article-title":"Spleen tyrosine kinase (SYK) is a potential target for the treatment of cutaneous lupus erythematosus patients","volume":"25","author":"Braegelmann","year":"2016","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.clim.2024.110231_bb0505","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/exd.13018","article-title":"The role of Syk in cutaneous lupus erythematosus","volume":"25","author":"Deng","year":"2016","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.clim.2024.110231_bb0510","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/77296","article-title":"Prevention of systemic lupus erythematosus in MRL\/lpr mice by administration of an immunoglobulin-binding peptide","volume":"18","author":"Marino","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.clim.2024.110231_bb0515","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1002\/art.27534","article-title":"Targeted tumor necrosis factor receptor I preligand assembly domain improves skin lesions in MRL\/lpr mice","volume":"62","author":"Deng","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2024.110231_bb0520","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","article-title":"Update \u03bfn the diagnosis and management of systemic lupus erythematosus","volume":"80","author":"Fanouriakis","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2024.110231_bb0525","first-page":"423","article-title":"The diagnosis and treatment of systemic lupus erythematosus","volume":"112","author":"Kuhn","year":"2015","journal-title":"Deutsches Arzteblatt Intern."},{"key":"10.1016\/j.clim.2024.110231_bb0530","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-4939-0326-9_4","article-title":"Tests for circulating immune complexes","volume":"1134","author":"Wener","year":"2014","journal-title":"Methods Mol. Biol. (Clifton, N.J.)"},{"key":"10.1016\/j.clim.2024.110231_bb0535","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/art.1780230302","article-title":"Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus","volume":"23","author":"Abrass","year":"1980","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2024.110231_bb0540","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2014-000056","article-title":"Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements","volume":"1","author":"Putterman","year":"2014","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.clim.2024.110231_bb0545","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1172\/JCI112119","article-title":"Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b","volume":"76","author":"Aguado","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2024.110231_bb0550","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/annrheumdis-2018-214598","article-title":"Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database","volume":"78","author":"Arnaud","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2024.110231_bb0555","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0140-6736(18)32167-6","article-title":"Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study","volume":"392","author":"van Vollenhoven","year":"2018","journal-title":"Lancet (Lond. Engl.)"},{"key":"10.1016\/j.clim.2024.110231_bb0560","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/art.41179","article-title":"Maintenance of efficacy and safety of Ustekinumab through one year in a phase II multicenter, prospective, randomized, double-blind, placebo-controlled crossover trial of patients with active systemic lupus erythematosus","volume":"72","author":"van Vollenhoven","year":"2020","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624003401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624003401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T19:44:33Z","timestamp":1715975073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661624003401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":112,"alternative-id":["S1521661624003401"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2024.110231","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal models of studying the pathogenesis of multi-organ tissue damage in lupus","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2024.110231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110231"}}